Thrombosis at the site of arterial puncture is a common and serious complication of percutaneous cardiac catheterization in children. A double-blind study was therefore designed to test the efficacy of heparin administered during catheterization in reducing this complication. One hundred and sixty-one unselected children over one year of age were studied. Prior to catheterization, the pulse amplitudes were measured in both legs using a Pulse Volume Recorder (a standardized oscillometer). Immediately after arterial cannulation, heparin, 1 mg/kg, or a placebo was administered. On the morning following catheterization, the pulse amplitude in both legs was remeasured and a pulse volume index calculated using the uncatheterized leg as a control. Patients in whom the catheterized leg was cold, with poor capillary filling and absent arterial pulses four hours after the completion of catheterization, were started on intravenous infusion of heparin. If no improvement occurred within 48 hours, embolectomy was performed.
amplitude in both legs was remeasured and a pulse volume index calculated using the uncatheterized leg as a control. Patients in whom the catheterized leg was cold, with poor capillary filling and absent arterial pulses four hours after the completion of catheterization, were started on intravenous infusion of heparin. If no improvement occurred within 48 hours, embolectomy was performed.
There was no evidence of arterial compromise to the catheterized extremity to any patient older than 10 years. Of 77 children ten years of age or younger, systemic heparinization posteatheterization was required for a pulseless extremity in 40% (15/37) of those in the placebo group and 8% (3/40) in the heparin group (P = 0.003). Only 5% (2/40) of children in the heparinized group had a pulse volume index of less than 50%, compared to 27% (10/37) Immediately after inserting the arterial catheter into the common femoral artery, the children were given 0.1 ml/kg from a numbered syringe containing a placebo or heparin. Duiring catheterization, the presence of a distal pulse in the femoral, dorsalis pedal, or posterior tibial arteries was ascertained while the largest catheter was in place. At the coenclusion of the catheterization, the arterial catheter was removed and the presence or absence of visible thrombus material on the tip of the catheter noted. Hemostasis was achieved by digital pressure, and the children were returned to the ward with an Elastoplast pressure dressing.
If both posterior tibial and dorsalis pedal pulse were absent four hours after catheterization and the leg was cold vith poor capillary filling, heparin, 1 mg/kg, was given intravenously and repeated every 4-6 hours, depending on clotting time. Amplitude of the pulses in both legs was remeasured using the Pulse Volume Recorder the morning following catheterization by the same technician using the same pressure and volume to inflate the cuff. If the distal pulses were not palpable 48 hours after catheterization, and the extremity remained cold with poor capillary filling, surgical embolectomy under general anesthesia was performed. Posteatheterization bleeding was evaluated the morning folloving catheterization upon changing the dressing. Bleeding was graded as none, mild (not requiring a change of the dressing), moderate (requiring a change of dressing), or severe (requiring protamine to reverse anticoagulation).
A pulse volume index (PVI) was calculated using the noncatheterized leg as a control by the equation: 
Results
Heparin reduced the incidence of arterial spasm and thrombosis as measured by a) the need to institute postcatheterization systemic heparinization, b) the pulse volume index, and c) the need for surgical exploration and embolectomy.
The occurrence of postcatheterization arterial spasm and thrombosis was directly related to the age of the patient on whom the procedure was performed. Children under five years of age were at greatest risk. Systemic heparinization postcatheterization was required in 38% (11/29) of children five years of age or less, and in 15% (7/48) of those six to ten years old. Embolectomy was required in 14% (4/29) of children at or under five years of age and in 6% (3/48) of those between six and ten years old. No one 11 years of age or older (84 children or 52% of our total group) required systemic heparinization (P -0.001) or embolectomy (P= 0.01).
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Because there was no evidence that the arterial circulation of the catheterized leg was compromised in children over ten, the data on the efficacy of heparin vs placebo has been analyzed for only the 77 children ten years of age or younger (table 1) . Forty received heparin at catheterization and 37 were in the placebo group.
Systemic heparinization four hours after catheterization was required because of the development of a cool, pulseless extremity in 40% (15/37) of the children in the placebo group compared to 8% (3/40) of the group receiving heparin during catheterization (P = 0.003). Twenty-seven percent of the children in the placebo group (10/37) had a pulse volume index less than 50% compared to 5% (2/40) of children in the heparinized group (P= 0.003) ( fig. 2) . In 19% (7/37) of the children in the placebo group, the catheterized leg remained cold 48 hours after catheterization and surgical exploration was performed. At surgery, a clot was noted at the puncture site in all seven and an embolectomy was performed without complications. Embolectomy was not necessary in any of the 40 children in the heparin group (P= 0.01).
A notation on the presence or absence of distal pulses was made during catheterization in 121 children. Systemic heparinization after catheterization was required in 38% (5/13) of those who had no palpable pulsations during the procedure compared to 6%r (7/108) of those who had a palpable pulse during catheterization (P = 0.002).
Inspection of the catheter after its removal from the artery in 144 children revealed a very high incidence of thrombi within the lumen of the catheter in the placebo group (21/77 or 27%) compared to the group receiving heparin (2/67 or 3%) (P 0.002), although there was no gross evidence of systemic arterial embolization in either group.
No correlation between postcatheterization heparinization, PVI, or embolectomy was found with respect to sex, duration of arteriotomy, size of the catheter used, thrombi in the arterial catheter, hematocrit, diagnosis, or postcatheterization bleeding. Table 1 Tihe Effect of Heparinizatiotn During Catheterization on Arterial Thrombosis Postcatheterization (Children No complications related to heparin were noted during this study, and the incidence of postcatheterization bleeding was not significantly different between the heparin and the placebo group (P = 0.70). Our clinical impression, however, was that a longer period of pressure over the artery to obtain hemostasis was needed in those who were anticoagulated. Protamine to correct a prolonged clotting time was not required in any patient.
Discussion
Our study demonstrates that heparin administered during cardiac catheterization is effective in preventing arterial spasm and thrombosis in children ten years of age and under.
While the exact mechanism of postcatheterization thrombus formation is still incompletely understood, Nejad et al." in dogs and Siegelman et al. 12 and later Formanek et al.'3 in humans have shown in elegant studies that one mechanism of thrombosis is stripping off of fibrinous material that has accumulated on the catheter surface when the catheter is being withdrawn through the small hole in the artery. Although some materials seem more thrombogenic than others,11 13 no material now in use is entirely devoid of this hazard. Systemic heparinization in animals prevents or retards the formation of these fibrin deposits,"1 14. 15 and in humans, decreases the incidence of thromboembol ism. [4] [5] [6] We also demonstrated a significantly lower in- FREED, KEANE, ROSENTHAL cidence of catheter clots in the heparinized group. It is likely, therefore, that heparinization during catheterization may prevent or retard the formation of thrombus on the catheter and the subsequent propagation in the vessel lumen, and thus prevent arterial occlusion by thrombus.
The frequency of compromise of the arterial circulation in our series is considerably higher than that quoted in the literature2' 3 but similar to our previous experience.' We feel that the reason for the discrepancy may be that many cardiologists have been inadvertently anticoagulating their patients by using high concentrations of heparin in the flush solutions. While we have not demonstrated the efficacy of heparin in preventing compromise to the arterial circulation in children over ten years of age, others' have suggested its usefulness. Several studies4`6 have demonstrated that heparinization during catheterization will drastically reduce the incidence of thromboembolism. For these reasons we recommend that all children undergoing percutaneous cardiac catheterization be given 1 mg/kg of heparin intravenously immediately after arterial cannulation unless a specific contraindication to the use of heparin exists. If within 4-6 hours after catheterization, the arterial pulse has not returned, the child should be maintained on systemic heparinization (1 mg/kg i.v. every 4-6 hours depending on clotting time). If the pulses in the catheterized extremity have not returned within 48 hours, even without other evidence of arterial compromise of the circulation, surgical embolectomy is probably indicated.
Circulation. 5 olmtnie 50, September 1974
